Gen1E Lifesciences Inc
Advertisement
GEn1E Lifesciences Inc, based in Palo Alto, California, is a clinical-stage company focused on accelerating first-in-class precision therapies for inflammatory rare diseases. With a robust pipeline featuring three key programs, the company has progressed from Early Discovery to Phase 2 in just 2.5 years, utilizing novel therapies that target kinase dysregulation effectively.
The company's innovative GRID AI platform leverages a rich database and machine learning models to streamline drug discovery and development, aiming to address significant unmet medical needs. GEn1E's differentiated approach to developing selective dual signal modifiers offers a promising alternative to traditional kinase inhibitors, minimizing immunosuppressive effects and enhancing therapeutic specificity.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement